Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial.
Saved in:
| Title: | Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial. |
|---|---|
| Authors: | Zarbock A; Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany., Larsson TE; Guard Therapeutics International AB, Stockholm, Sweden., Noiseux N; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada., Mazer CD; St. Michael's Hospital, University of Toronto, Toronto, Canada., Böhm J; Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Technical University of Munich, Munich, Germany., Laflamme M; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada., Matschke K; Klinik für Herzchirurgie, Herzzentrum Dresden Universitätsklinik, Dresden, Germany., Burkert J; Fakultni Nemocnice v Motole, Prague, Czech Republic., de Varennes B; McGill University Health Centre - Royal Victoria Hospital, Montréal, Canada., Myjavec A; Department of Cardiac Surgery, Charles University, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic., Böning A; Department of Cardiovascular Surgery, Justus-Liebig-University Giessen, Germany., Koyner JL; Section of Nephrology, University of Chicago, Chicago, IL, USA., Engelman D; Division of Cardiac Surgery, Baystate Medical Center, Springfield, MA, USA., Reusch M; Guard Therapeutics International AB, Stockholm, Sweden., Thielmann M; Klinik für Thorax- und Kardiovaskuläre Chirurgie, Westdeutsches Herz- und Gefäßzentrum Essen, Universität Duisburg-Essen, Germany. |
| Corporate Authors: | AKITA investigators |
| Source: | EClinicalMedicine [EClinicalMedicine] 2024 Sep 16; Vol. 76, pp. 102830. Date of Electronic Publication: 2024 Sep 16 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39318788 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zarbock+A%22">Zarbock A</searchLink>; Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Larsson+TE%22">Larsson TE</searchLink>; Guard Therapeutics International AB, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Noiseux+N%22">Noiseux N</searchLink>; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Mazer+CD%22">Mazer CD</searchLink>; St. Michael's Hospital, University of Toronto, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Böhm+J%22">Böhm J</searchLink>; Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Technical University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Laflamme+M%22">Laflamme M</searchLink>; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Matschke+K%22">Matschke K</searchLink>; Klinik für Herzchirurgie, Herzzentrum Dresden Universitätsklinik, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Burkert+J%22">Burkert J</searchLink>; Fakultni Nemocnice v Motole, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22de+Varennes+B%22">de Varennes B</searchLink>; McGill University Health Centre - Royal Victoria Hospital, Montréal, Canada.<br /><searchLink fieldCode="AU" term="%22Myjavec+A%22">Myjavec A</searchLink>; Department of Cardiac Surgery, Charles University, Faculty of Medicine and University Hospital in Hradec Kralove, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Böning+A%22">Böning A</searchLink>; Department of Cardiovascular Surgery, Justus-Liebig-University Giessen, Germany.<br /><searchLink fieldCode="AU" term="%22Koyner+JL%22">Koyner JL</searchLink>; Section of Nephrology, University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Engelman+D%22">Engelman D</searchLink>; Division of Cardiac Surgery, Baystate Medical Center, Springfield, MA, USA.<br /><searchLink fieldCode="AU" term="%22Reusch+M%22">Reusch M</searchLink>; Guard Therapeutics International AB, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Thielmann+M%22">Thielmann M</searchLink>; Klinik für Thorax- und Kardiovaskuläre Chirurgie, Westdeutsches Herz- und Gefäßzentrum Essen, Universität Duisburg-Essen, Germany. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22AKITA+investigators%22">AKITA investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2024 Sep 16; Vol. 76, pp. 102830. <i>Date of Electronic Publication: </i>2024 Sep 16 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39318788 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.eclinm.2024.102830 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102830 Titles: – TitleFull: Efficacy and safety of therapeutic alpha-1-microglobulin RMC-035 in reducing kidney injury after cardiac surgery: a multicentre, randomised, double-blind, parallel group, phase 2a trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zarbock A – PersonEntity: Name: NameFull: Larsson TE – PersonEntity: Name: NameFull: Noiseux N – PersonEntity: Name: NameFull: Mazer CD – PersonEntity: Name: NameFull: Böhm J – PersonEntity: Name: NameFull: Laflamme M – PersonEntity: Name: NameFull: Matschke K – PersonEntity: Name: NameFull: Burkert J – PersonEntity: Name: NameFull: de Varennes B – PersonEntity: Name: NameFull: Myjavec A – PersonEntity: Name: NameFull: Böning A – PersonEntity: Name: NameFull: Koyner JL – PersonEntity: Name: NameFull: Engelman D – PersonEntity: Name: NameFull: Reusch M – PersonEntity: Name: NameFull: Thielmann M IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 09 Text: 2024 Sep 16 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2589-5370 Numbering: – Type: volume Value: 76 Titles: – TitleFull: EClinicalMedicine Type: main |
| ResultId | 1 |